Director's Dealing • Sep 30, 2022
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
Convatec Group PLC (CTEC)
Convatec Group PLC: Director/ PDMR Shareholding
30-Sep-2022 / 13:19 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
30 September 2022
Convatec Group Plc
("Convatec" or "the Company")
Director/ PDMR Shareholding
The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 30 September 2022, Constantin Coussios, Non-Executive Director and PDMR, purchased 9,861 Shares of 10 pence in the Company. Constantin Coussios’ resulting shareholding is 18,301 Shares.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Constantin Coussios | ||
| 2 | Reason for the notification | |||
| a) | Position/Status | Non-Executive Director | ||
| b) | Initial notification/Amendment | Initial notification | ||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||
| a) | Name | Convatec Group Plc | ||
| b) | LEI | 213800LS272L4FIDOH92 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary share of 10p each in Convatec Group Plc GB00BD3VFW73 |
||
| b) | Nature of the transaction | Purchase of Ordinary shares of 10p each in Convatec Group Plc | ||
| c) | Price(s) and volume(s) | Price(s) £2.04892 |
Volume(s) 9,861 |
|
| d) | Aggregated information - Aggregated volume - Price |
N/A N/A |
||
| e) | Date of the transaction | 2022-09-30 | ||
| f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, Convatec +44 (0)782 644 7807
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 100 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over $2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http://www.convatecgroup.com
| ISIN: | GB00BD3VFW73 |
| Category Code: | DSH |
| TIDM: | CTEC |
| LEI Code: | 213800LS272L4FIDOH92 |
| Sequence No.: | 191553 |
| EQS News ID: | 1454167 |
| End of Announcement | EQS News Service |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.